Literature DB >> 1270578

Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.

S M Guerra, A E Kitabchi.   

Abstract

The difference in absorption of insulin and its glucose lowering-effect after the administration of crystalline insulin by the intravenous, intramuscular, and subcutaneous routes was compared in 14 lean normal subjects. Insulin in a dose of 0.1 U/kg body weight was given by the three different routes. Blood was drawn from the opposite arm at regular intervals for the determination of insulin, glucose, glucagon, cortisol, and potassium. Intravenous insulin produced the highest pharmacological level of insulin in 2 minutes (2099 +/- 414 muU/ml) with marked hypoglycemia at 30 minutes (a 68% drop). Intravenous insulin injection produced an increase in plasma glucagon and cortisol reaching a 2-fold increase above the fasting level 30 minutes after the glucose nadir. An equivalent amount of intramuscular insulin produced a maximal increase in plasma insulin at 50 minutes (45 +/- 4 muU/ml) and caused a 35% drop in plasma glucose at 60 minutes, which effects were greater than those caused by subcutaneous injection (highest IRI = 36 +/- 3.5 muU/ml and 23% glucose drop at 180 minutes). No significant increase in glucagon or cortisol was noted with equivalent amounts of subcutaneous or intramuscular insulin injection. Our studies suggest that, in normal lean subjects, insulin injection by the intramuscular route provides a faster absorption of insulin with a concomitant greater drop in plasma glucose than does injection by the subcutaneous route.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270578     DOI: 10.1210/jcem-42-5-869

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Diabetic ketoacidosis.

Authors:  Kristina Casteels; Chantal Mathieu
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Hormonal regulation of potassium shifts during graded exhausting exercise.

Authors:  F J Laso; J M González-Buitrago; C Martín Ruiz; S de Castro
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

3.  Effect of diabetes on serum potassium concentrations in acute coronary syndromes.

Authors:  K Foo; N Sekhri; A Deaner; C Knight; A Suliman; K Ranjadayalan; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

4.  Insulin regimens for diabetic ketoacidosis.

Authors: 
Journal:  Br Med J       Date:  1977-02-12

5.  Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.

Authors:  R W Stevenson; T I Tsakok; J A Parsons
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

Review 6.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

7.  Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.

Authors:  J Rosenstock; S A Loizou; I E Brajkovich; K Mashiter; G F Joplin
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

8.  Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.

Authors:  D J Chisholm; E W Kraegen; M J Hewett; S Furler
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

9.  Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.

Authors:  M Takeyama; T Ishida; N Kokubu; F Komada; S Iwakawa; K Okumura; R Hori
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

10.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.

Authors:  G F Maberly; G A Wait; J A Kilpatrick; E G Loten; K R Gain; R D Stewart; C J Eastman
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.